| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.33M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LTRN returned -52.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -29.8% |
| 1 year | -52.8% |
| 5 years | -84.9% |
| All-time high | $19.25 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in LTRN would be worth today ›No. Lantern Pharma Inc. has not paid a dividend in the past 12 months.
Lantern Pharma Inc. stock trades on NASDAQ under the ticker symbol LTRN.
Lantern Pharma Inc. is part of the Healthcare sector.
Lantern Pharma Inc. has a market cap of 27.21M USD, based on the latest quote.
Lantern Pharma Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
